Get started
Live feed
INSIDERFilingvia Quantisnow
Context Therapeutics Inc. logo

Context Therapeutics (CNTX): SEC Form 3: New insider Kantoff Philip W. claimed ownership of 3,533 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Context Therapeutics Inc. logo
CNTX
Context Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for CNTX

Follow CNTX and get a push notification the moment its next story breaks.

Full CNTX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTX (Context Therapeutics Inc.) and more on Quantisnow.